SEC Form 4 · accession 0001567619-19-000256
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Hollingshead
Officer — President, Americas
Period of report
Jan 2, 2019
Accepted (ET)
Jan 3, 2019 · 4:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Jan 2, 2019 | M | 800 | $58.24 | A | 84,489 | D | |
| ResMed Common Stock | Jan 2, 2019 | S | 800 | $112.13 | D | 83,689 | D | |
| ResMed Common Stock | Jan 2, 2019 | S | 800 | $112.13 | D | 82,889 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF2 | $58.24 | Jan 2, 2019 | M | 800 | D | Nov 11, 2016 | Nov 19, 2022 | ResMed Commmon Stock | 800 | 28,838 | D |
Explanation of responses
- F1The transaction was conducted under a Rule 10b5-1 plan.
- F2Represents date options first became exercisable. Options vest 1/3 per year.